EARNEST Partners’s bluebird bio BLUE Stock Holding History

EARNEST Partners’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$79	–	389
2023 Q3	$79	Hold	1	–	–	﹤0.01%	1156
2023 Q2	$86	Hold	1	–	–	﹤0.01%	1164
2023 Q1	$83	Hold	1	–	–	﹤0.01%	1160
2022 Q4	$180	Hold	1	–	–	﹤0.01%	1157
2022 Q3	$0	Hold	1	–	–	﹤0.01%	1128
2022 Q2	$0	Hold	1	–	–	﹤0.01%	1150
2022 Q1	$0	Hold	1	–	–	﹤0.01%	1154
2021 Q4	$0	Sell	1 -1	-50%	-$236	﹤0.01%	1167
2021 Q3	$0	Hold	2	–	–	﹤0.01%	1167
2021 Q2	$1K	Hold	2	–	–	﹤0.01%	1095
2021 Q1	$1K	Hold	2	–	–	﹤0.01%	1104
2020 Q4	$1K	Hold	2	–	–	﹤0.01%	1085
2020 Q3	$1K	Hold	2	–	–	﹤0.01%	1035
2020 Q2	$2K	Hold	2	–	–	﹤0.01%	918
2020 Q1	$1K	Hold	2	–	–	﹤0.01%	966
2019 Q4	$2K	Hold	2	–	–	﹤0.01%	980
2019 Q3	$2K	Hold	2	–	–	﹤0.01%	963
2019 Q2	$3K	Hold	2	–	–	﹤0.01%	891
2019 Q1	$4K	Hold	2	–	–	﹤0.01%	801
2018 Q4	$3K	Hold	2	–	–	﹤0.01%	839
2018 Q3	$4K	Hold	2	–	–	﹤0.01%	836
2018 Q2	$4K	Buy	+2	New	+$4.56K	﹤0.01%	824

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

EARNEST Partners's BLUE Position: Q4 2023 in Review

EARNEST Partners sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 1 share — an estimated $79 sold.

EARNEST Partners first reported a position in BLUE in Q2 2018 and held it in 22 quarters. The position peaked at $4K in Q1 2019. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

EARNEST Partners reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 1 bluebird bio share in Q4 2023, an estimated $79.
EARNEST Partners first reported a position in bluebird bio in Q2 2018 and held it in 22 quarters.
EARNEST Partners's bluebird bio position peaked at $4K in Q1 2019.
187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.